MAMH gapping BIGTIME! MAMMATECH CORPORATION (OTC BB: MAMH) has signed a sale and distribution agreement with a German health care products company. This agreement provides exclusive distribution rights for the Company's products throughout Germany and the German-speaking portions of Austria, Switzerland, and Belgium. In return, the distributor has undertaken at its own expense to provide translations of the Company's Personal Learning System video tape and printed materials. The distributor has also launched an extensive promotional campaign in both the electronic and print media. The shipment of 75,000 MammaCare units will be commenced within 6 months and the revenues from the first shipment will be about $15 million with at least $3 million net earnings ($0.03/share). This is the first step for the Company to fully launch its patented MammaCare products worldwide. The Company is also negotiating sale and distribution agreements with a member of the Korean Health Care industry and a member of the Japanese Health Care industry. The completion of these negotiations will add more revenues in addition to our current distribution in Europe in 1998.
Mammatech Corporation owns all rights to, subject to certain minor royalties, and is engaged in the sale of a patented breast tumor detection training system (the "MammaCare System") worldwide. Using lifelike models of a human female breast, the MammaCare System is designed to train women to perform effective Breast Self-Examination. The breast models contain simulated tumors of varying sizes, ranging from under 5mm. to over 10mm. They also contain material which simulates the normal nodularity, or "lumpiness", that characterizes most breast tissue.
ÿ
*Found the above on Yahoo board. Also "rumours" of Merck buyout. |
